At close: December 20 at 5:29:32 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in SEK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 4 |
| Avg. Estimate | -0.23 | -0.22 | -0.9 | -0.15 |
| Low Estimate | -0.23 | -0.22 | -1.02 | -0.76 |
| High Estimate | -0.23 | -0.22 | -0.81 | 0.54 |
| Year Ago EPS | -0.3 | -0.3 | -1.3 | -0.9 |
Revenue Estimate
| Currency in SEK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 5 | 6 |
| Avg. Estimate | 16M | 18M | 55.02M | 263.45M |
| Low Estimate | 16M | 18M | 47M | 120.8M |
| High Estimate | 16M | 18M | 65M | 573.54M |
| Year Ago Sales | 32.6M | 12.1M | 57.6M | 55.02M |
| Sales Growth (year/est) | -50.92% | 48.76% | -4.47% | 378.79% |
Earnings History
| Currency in SEK | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.31 | -0.3 | -0.32 |
| EPS Actual | -0.3 | -0.3 | -0.2 | -0.3 |
| Difference | 0.02 | 0.01 | 0.1 | 0.02 |
| Surprise % | 6.81% | 1.77% | 32.23% | 5.48% |
EPS Trend
| Currency in SEK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.22 | -0.9 | -0.15 |
| 7 Days Ago | -0.32 | -0.2 | -0.92 | 0.05 |
| 30 Days Ago | -0.29 | -0.2 | -0.92 | 0.05 |
| 60 Days Ago | -0.29 | -0.2 | -0.81 | 0.07 |
| 90 Days Ago | -0.29 | -0.2 | -0.81 | 0.07 |
EPS Revisions
| Currency in SEK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EGTX.ST | 23.67% | 26.67% | 30.42% | 83.47% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
XBRANE.ST Xbrane Biopharma AB (publ)
0.1560
-4.29%
VICO.ST Vicore Pharma Holding AB (publ)
7.86
+2.75%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%
ONCO.ST Oncopeptides AB (publ)
1.5080
-1.69%
BIOVIC-B.ST Biovica International AB (publ)
1.7380
+8.63%
ACE.ST Ascelia Pharma AB (publ)
3.0000
-0.33%
HNSA.ST Hansa Biopharma AB (publ)
38.88
+6.11%
MVIR.ST Medivir AB (publ)
2.7600
-1.08%
AELIS.PA Aelis Farma SA
2.0800
0.00%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
11.10
+1.83%